Moderna Inc (MRNA)

$ 26.22
   
  • Change Today:
    $-0.67
  • 52 Week High: $89.96
  • 52 Week Low: $23.65
  • Currency: US Dollars
  • Shares Issued: 386.00m
  • Volume: 5,643,695
  • Market Cap: $10,121m
  • RiskGrade: 392

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 3,236.00 6,848.00 19,263.00 18,471.00 803.40
Operating Profit/(Loss) (3,945.00) (4,239.00) 9,420.00 13,296.00 (763.14)
Profit Before Tax (3,607.00) (3,942.00) 9,575.00 13,285.00 (744.51)
Profit After Tax (3,561.00) (4,714.00) (8,362.00) 12,202.00 (747.06)
           
Earnings per Share - Basic (928.00¢) (1,233.00¢) 2,126.00¢ 3,031.00¢ (196.00¢)
Earnings per Share - Adjusted (928.00¢) (1,233.00¢) 2,126.00¢ 3,031.00¢ (196.00¢)
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 2,955.00 2,658.00 2,139.00 1,383.00 387.09
Intangible Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 3,088.00 5,443.00 10,288.00 7,215.00 651.78
  6,043.00 8,101.00 12,427.00 8,598.00 1,038.87
Current Assets          
Inventories 117.00 202.00 949.00 1,441.00 46.53
Cash at Bank & in Hand 1,927.00 2,907.00 3,205.00 6,848.00 2,623.85
Other Current Assets 6,055.00 7,216.00 9,277.00 7,782.00 3,627.50
  8,099.00 10,325.00 13,431.00 16,071.00 6,297.88
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 14,142.00 18,426.00 25,858.00 24,669.00 7,336.75
Current Liabilities          
Borrowings n/a n/a n/a n/a n/a
Other Current Liabilities 2,206.00 3,015.00 4,923.00 9,128.00 4,388.81
           
Current Liabilities 2,206.00 3,015.00 4,923.00 9,128.00 4,388.81
           
Net Current Assets c5,893.00 c7,310.00 c8,508.00 c6,943.00 c1,909.07
           
Borrowings 710.00 1,218.00 1,004.00 705.00 207.29
Other Non-Current Liabilities 325.00 339.00 808.00 691.00 179.27
Non-Current Liabilities 1,035.00 1,557.00 1,812.00 1,396.00 386.57
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 3,241.00 4,572.00 6,735.00 10,524.00 4,775.38
           
Net Assets 10,901.00 13,854.00 19,123.00 14,145.00 2,561.38
           
Shareholders Funds 10,901.00 13,854.00 18,320.00 14,145.00 2,561.38
           
Minority Interests/Other Equity n/a n/a 803.00 n/a n/a
Total Equity 10,901.00 13,854.00 19,123.00 14,145.00 2,561.38
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities (3,004.00) (3,118.00) 4,981.00 13,620.00 2,027.00
Net Cash Flow from Investing Activities 1,949.00 4,206.00 (5,176.00) (8,523.00) (1,672.00)
Net Cash Flow from Financing Activities 56.00 (1,377.00) (3,448.00) (873.00) 2,033.00
Net Increase/Decrease In Cash (999.00) (289.00) (3,643.00) 4,224.00 2,388.00
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted n/a n/a 8.4 8.4 n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a -30% n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 838.34¢ 1,774.09¢ 4,990.41¢ 48.30¢ 208.13¢
Pre-Tax Profit per Share (934.46¢) (1,021.24¢) 2,480.57¢ 34.74¢ (192.88¢)
Operating Margin (121.91%) (61.90%) 48.90% 71.98% (94.99%)
Return on Capital Employed n/a n/a 47.57% 0.90% n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share (778.24¢) (807.77¢) 1,290.41¢ 3,528.50¢ 525.13¢
Cash Incr/Decr per Share (258.81¢) (74.87¢) (943.78¢) 11.05¢ 618.65¢
Net Asset Value per Share (exc. Intangibles) 2,824.09¢ 3,589.12¢ 4,954.15¢ 3,664.51¢ 663.57¢
Net Gearing -11.16% -12.19% -12.01% -43.43% -94.35%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page